Skip to main content
NCBI home page
Gut logoLink to Gut
. 1998 Jul;43(Suppl 1):S35–S38. doi: 10.1136/gut.43.2008.s35

Acid suppression and gastric atrophy: sifting fact from fiction

R Genta
PMCID: PMC1766607  PMID: 9764038

Full Text

The Full Text of this article is available as a PDF (131.2 KB).

Figure 1 .

Figure 1

Open in a new tab

(A) Normal gastric corpus mucosa. Glands are tightly packed and there are few inflammatory cells in the subepithelial area and in between the glands. (B) Severe corpus gastritis with probable atrophy. Islands of glands are separated by large numbers of inflammatory cells and fibrous tissue. 


Figure 2 .

Figure 2

Open in a new tab

In H pylori infected patients who receive proton pump inhibitors for extended periods the pattern of gastritis changes from antral predominant to corpus predominant. The bacterial density tends to decrease in the antrum whereas it remains essentially unchanged in the corpus. 


Figure 3 .

Figure 3

Open in a new tab

(A) Moderate corpus gastritis, oxyntic gland dilatation and "pseudo-hyperplasia" in a H pylori infected patient receiving proton pump inhibitors. (B) At high magnification, H pylori can be seen in the deep portion of the oxyntic glands and within the canaliculi of the parietal cells. 


Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen L. P., Gaarslev K. IgG subclass antibodies against Helicobacter pylori heat-stable antigens in normal persons and in dyspeptic patients. APMIS. 1992 Aug;100(8):747–751. [PubMed] [Google Scholar]
  2. Asaka M., Kato M., Kudo M., Katagiri M., Nishikawa K., Yoshida J., Takeda H., Miki K. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. Eur J Gastroenterol Hepatol. 1995 Aug;7 (Suppl 1):S7–10. [PubMed] [Google Scholar]
  3. Calam J. Helicobacter pylori, acid and gastrin. Eur J Gastroenterol Hepatol. 1995 Apr;7(4):310–317. [PubMed] [Google Scholar]
  4. Calam J. The somatostatin-gastrin link of Helicobacter pylori infection. Ann Med. 1995 Oct;27(5):569–573. doi: 10.3109/07853899509002471. [DOI] [PubMed] [Google Scholar]
  5. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988 Jul 1;48(13):3554–3560. [PubMed] [Google Scholar]
  6. Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol Suppl. 1984;104:131–136. [PubMed] [Google Scholar]
  7. Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol. 1988 May;83(5):504–509. [PubMed] [Google Scholar]
  8. Correa P., Haenszel W., Cuello C., Zavala D., Fontham E., Zarama G., Tannenbaum S., Collazos T., Ruiz B. Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res. 1990 Aug 1;50(15):4731–4736. [PubMed] [Google Scholar]
  9. Daw M. A., Deegan P., Leen E., O'Moráin C. Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis. Aliment Pharmacol Ther. 1991 Aug;5(4):435–439. doi: 10.1111/j.1365-2036.1991.tb00047.x. [DOI] [PubMed] [Google Scholar]
  10. Dickey W., Kenny B. D., McConnell J. B. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Ther. 1996 Jun;10(3):289–293. doi: 10.1111/j.0953-0673.1996.00289.x. [DOI] [PubMed] [Google Scholar]
  11. Dixon M. F., Genta R. M., Yardley J. H., Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996 Oct;20(10):1161–1181. doi: 10.1097/00000478-199610000-00001. [DOI] [PubMed] [Google Scholar]
  12. Driman D. K., Wright C., Tougas G., Riddell R. H. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig Dis Sci. 1996 Oct;41(10):2039–2047. doi: 10.1007/BF02093608. [DOI] [PubMed] [Google Scholar]
  13. Eissele R., Brunner G., Simon B., Solcia E., Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology. 1997 Mar;112(3):707–717. doi: 10.1053/gast.1997.v112.pm9041231. [DOI] [PubMed] [Google Scholar]
  14. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol Suppl. 1996;215:48–51. [PubMed] [Google Scholar]
  15. Genta R. M., Graham D. Y. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc. 1994 May-Jun;40(3):342–345. doi: 10.1016/s0016-5107(94)70067-2. [DOI] [PubMed] [Google Scholar]
  16. Genta R. M. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol. 1996;20 (Suppl 1):S23–S30. doi: 10.1097/00000478-199600001-00004. [DOI] [PubMed] [Google Scholar]
  17. Holcombe C., Omotara B. A., Eldridge J., Jones D. M. H. pylori, the most common bacterial infection in Africa: a random serological study. Am J Gastroenterol. 1992 Jan;87(1):28–30. [PubMed] [Google Scholar]
  18. Holcombe C., Umar H., Lucas S. B., Kaluba J. Low incidence of clinically significant gastroduodenal pathology despite a high incidence of Helicobacter pylori infection. Trans R Soc Trop Med Hyg. 1994 Sep-Oct;88(5):569–571. doi: 10.1016/0035-9203(94)90166-x. [DOI] [PubMed] [Google Scholar]
  19. Krishnamurthy S., Dayal Y. Parietal cell protrusions in gastric ulcer disease. Hum Pathol. 1997 Oct;28(10):1126–1130. doi: 10.1016/s0046-8177(97)90249-5. [DOI] [PubMed] [Google Scholar]
  20. Kuipers E. J., Lundell L., Klinkenberg-Knol E. C., Havu N., Festen H. P., Liedman B., Lamers C. B., Jansen J. B., Dalenback J., Snel P. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996 Apr 18;334(16):1018–1022. doi: 10.1056/NEJM199604183341603. [DOI] [PubMed] [Google Scholar]
  21. Kuipers E. J., Uyterlinde A. M., Peña A. S., Hazenberg H. J., Bloemena E., Lindeman J., Klinkenberg-Knol E. C., Meuwissen S. G. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995 Sep;90(9):1401–1406. [PubMed] [Google Scholar]
  22. Kuipers E. J., Uyterlinde A. M., Peña A. S., Roosendaal R., Pals G., Nelis G. F., Festen H. P., Meuwissen S. G. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995 Jun 17;345(8964):1525–1528. doi: 10.1016/s0140-6736(95)91084-0. [DOI] [PubMed] [Google Scholar]
  23. Lamberts R., Creutzfeldt W., Strüber H. G., Brunner G., Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology. 1993 May;104(5):1356–1370. doi: 10.1016/0016-5085(93)90344-c. [DOI] [PubMed] [Google Scholar]
  24. Logan R. P., Walker M. M., Misiewicz J. J., Gummett P. A., Karim Q. N., Baron J. H. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut. 1995 Jan;36(1):12–16. doi: 10.1136/gut.36.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Malfertheiner P., Mégraud F., O'Morain C., Bell D., Bianchi Porro G., Deltenre M., Forman D., Gasbarrini G., Jaup B., Misiewicz J. J. Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997 Jan;9(1):1–2. doi: 10.1097/00042737-199701000-00002. [DOI] [PubMed] [Google Scholar]
  26. McCloy R. F., Arnold R., Bardhan K. D., Cattan D., Klinkenberg-Knol E., Maton P. N., Riddell R. H., Sipponen P., Walan A. Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci. 1995 Feb;40(2 Suppl):96S–120S. doi: 10.1007/BF02214874. [DOI] [PubMed] [Google Scholar]
  27. Nomura A., Yamakawa H., Ishidate T., Kamiyama S., Masuda H., Stemmermann G. N., Heilburn L. K., Hankin J. H. Intestinal metaplasia in Japan: association with diet. J Natl Cancer Inst. 1982 Mar;68(3):401–405. [PubMed] [Google Scholar]
  28. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–1131. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
  29. Parsonnet J. Helicobacter pylori in the stomach--a paradox unmasked. N Engl J Med. 1996 Jul 25;335(4):278–280. doi: 10.1056/NEJM199607253350411. [DOI] [PubMed] [Google Scholar]
  30. Price A. B. The Sydney System: histological division. J Gastroenterol Hepatol. 1991 May-Jun;6(3):209–222. doi: 10.1111/j.1440-1746.1991.tb01468.x. [DOI] [PubMed] [Google Scholar]
  31. Sipponen P., Kekki M., Haapakoski J., Ihamäki T., Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer. 1985 Feb 15;35(2):173–177. doi: 10.1002/ijc.2910350206. [DOI] [PubMed] [Google Scholar]
  32. Siurala M., Lehtola J., Ihamäki T. Atrophic gastritis and its sequelae. Results of 19-23 years' follow-up examinations. Scand J Gastroenterol. 1974;9(5):441–446. [PubMed] [Google Scholar]
  33. Stemmermann G. N. Intestinal metaplasia of the stomach. A status report. Cancer. 1994 Jul 15;74(2):556–564. doi: 10.1002/1097-0142(19940715)74:2<556::aid-cncr2820740205>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  34. Stolte M., Bethke B., Rühl G., Ritter M. Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol. 1992 Feb;30(2):134–138. [PubMed] [Google Scholar]
  35. Uemura N., Oomoto Y., Mukai T., Okamoto S., Yamaguchi S., Mashiba H., Taniyama K., Sasaki N., Sumii K., Haruma K. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients. Aliment Pharmacol Ther. 1997 Aug;11(4):793–800. doi: 10.1046/j.1365-2036.1997.00218.x. [DOI] [PubMed] [Google Scholar]
  36. Whitehead R. Gastritis--histopathological background. Scand J Gastroenterol Suppl. 1982;79:40–43. [PubMed] [Google Scholar]
  37. Whitehead R., Truelove S. C., Gear M. W. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol. 1972 Jan;25(1):1–11. doi: 10.1136/jcp.25.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. el-Zimaity H. M., Graham D. Y., al-Assi M. T., Malaty H., Karttunen T. J., Graham D. P., Huberman R. M., Genta R. M. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol. 1996 Jan;27(1):35–41. doi: 10.1016/s0046-8177(96)90135-5. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES